2025 European Society of Cardiology (Madrid)

Rahul Aggarwal – Validation of the DOAC Score among Patients on Vitamin K Antagonists

David Berg – DAPA ACT HF-TIMI 68-Dapagliflozin in Patients Hospitalized for Acute Heart Failure

Brian Bergmark – Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk-the Essence-TIMI 73b trial

Siddharth Patel – Prior anticoagulation experience, bleeding risk, and safety of factor XI inhibition in atrial fibrillation-an analysis of AZALEA-TIMI 71

Siddharth Patel – Renal function and factor XI inhibition in atrial fibrillation-a pre-specified analysis of AZALEA-TIMI 71

Andre Zimerman – Low-dose edoxaban in patients 80 years and older with atrial fibrillation and dose-reduction criteria-randomized analysis between edoxaban 15 mg and 30 mg

The association between sex and body size and stroke risk and survival in patients with atrial fibrillation an analysis of 71,589 patients from the COMBINE AF study

Regional differences in clinical outcomes in patients of Asian race with atrial fibrillation randomized to direct oral anticoagulants vs warfarin: a patient-level meta-analyses from COMBINE AF